Home » Sanofi Unwilling to Meet Both Genzyme Demands
Sanofi Unwilling to Meet Both Genzyme Demands
Sanofi-Aventis SA is unwilling to meet demands by Genzyme Corp. to both raise its $18.5 billion offer and make a later payment based on sales goals for the drug Campath, said three people with direct knowledge of the matter.
Bloomberg
Bloomberg
Upcoming Events
-
07May
-
14May
-
30May